Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Gong, Fengming ^a   Peng, Xingchen ^a   Luo, Can ^a   Shen, Guobo ^a   Zhao, Chengjian ^a   Zou, Liqun ^a   Li, Longhao ^a   Sang, Yaxiong ^a   Zhao, Yuwei ^a   Zhao, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

2 DE; Cathepsin B; Lung squamous cell carcinoma; Ptch; Shh

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN B; PROTEIN PATCHED; SHORT HAIRPIN RNA; SONIC HEDGEHOG PROTEIN;

ADULT; AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM BINDING; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; LUNG WEIGHT; MALE; METABOLISM; METASTASIS; METASTATIC LUNG SQUAMOUS CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEOMICS; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURVIVAL RATE; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME; TUMOR XENOGRAFT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ERINACEIDAE;

AGED; AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEOME; RETROSPECTIVE STUDIES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84888034043     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-125     Document Type: Article

References (27)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
2. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005, 16:481-488. 10.1093/annonc/mdi098, 15718248.
3. Kabuyama Y, Resing KA, Ahn NG. Applying proteomics to signaling networks. Curr Opin Genet Dev 2004, 14:492-498. 10.1016/j.gde.2004.07.001, 15380239.
4. Liu R, Li Z, Bai S, Zhang H, Tang M, Lei Y, Chen L, Liang S, Zhao YL, Wei Y, Huang C. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol Cell Proteomics 2009, 8:70-85. 10.1074/mcp.M800195-MCP200, 18723843.
5. Poschmann G, Sitek B, Sipos B, Ulrich A, Wiese S, Stephan C, Warscheid B, Kloppel G, Vander Borght A, Ramaekers FC, et al. Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol Cell Proteomics 2009, 8:1105-1116. 10.1074/mcp.M800422-MCP200, 2689775, 19176476.
6. Yao H, Zhang Z, Xiao Z, Chen Y, Li C, Zhang P, Li M, Liu Y, Guan Y, Yu Y, Chen Z. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 2009, 65:41-48. 10.1016/j.lungcan.2008.10.024, 19058872.
7. Xu Y, Cao LQ, Jin LY, Chen ZC, Zeng GQ, Tang CE, Li GQ, Duan CJ, Peng F, Xiao ZQ, Li C. Quantitative proteomic study of human lung squamous carcinoma and normal bronchial epithelial acquired by laser capture microdissection. J Biomed Biotechnol 2012, 2012:510418. 3303868, 22500095.
8. Tummalapalli P, Spomar D, Gondi CS, Olivero WC, Gujrati M, Dinh DH, Rao JS. RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. Int J Oncol 2007, 31:1039-1050. 2031211, 17912429.
9. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001, 411:375-379. 10.1038/35077241, 11357145.
10. Frlan R, Gobec S. Inhibitors of cathepsin B. Curr Med Chem 2006, 13:2309-2327. 10.2174/092986706777935122, 16918357.
11. Bengsch F, Buck A, Gunther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, et al. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene 2013
12. Lim IT, Meroueh SO, Lee M, Heeg MJ, Mobashery S. Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis. J Am Chem Soc 2004, 126:10271-10277. 10.1021/ja0489240, 15315439.
13. Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF. Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat Rec 1993, 235:233-240. 10.1002/ar.1092350207, 7678371.
14. Murnane MJ, Sheahan K, Ozdemirli M, Shuja S. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 1991, 51:1137-1142.
15. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 1994, 54:6027-6031.
16. Matarrese P, Ascione B, Ciarlo L, Vona R, Leonetti C, Scarsella M, Mileo AM, Catricala C, Paggi MG, Malorni W. Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study. Mol Cancer 2010, 9:207. 10.1186/1476-4598-9-207, 2925371, 20684763.
17. Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Muller S, Vasiljeva O, Schwinde A, Klemm N, Deussing J, et al. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci USA 2010, 107:2497-2502. 10.1073/pnas.0907240107, 2823914, 20133781.
18. Sevenich L, Werner F, Gajda M, Schurigt U, Sieber C, Muller S, Follo M, Peters C, Reinheckel T. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene 2011, 30:54-64. 10.1038/onc.2010.387, 20818432.
19. Gong F, Peng X, Zeng Z, Yu M, Zhao Y, Tong A. Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method. Mol Cell Biochem 2011, 348:141-147. 10.1007/s11010-010-0648-6, 21080034.
20. Rabilloud T, Adessi C, Giraudel A, Lunardi J. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1997, 18:307-316.
21. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 2004, 64:5232-5236. 10.1158/0008-5472.CAN-04-0272, 15289328.
22. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18:533-537. 10.1002/elps.1150180333, 9150937.
23. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 1996, 383:407-413. 10.1038/383407a0, 8837770.
24. Yang L, Xie G, Fan Q, Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010, 29:469-481. 10.1038/onc.2009.392, 19935712.
25. Xie J. Implications of hedgehog signaling antagonists for cancer therapy. Acta Biochim Biophys Sin (Shanghai) 2008, 40:670-680. 10.1111/j.1745-7270.2008.00431.x, 2515624, 18604459.
26. Xie J. Hedgehog signaling pathway: development of antagonists for cancer therapy. Curr Oncol Rep 2008, 10:107-113. 10.1007/s11912-008-0018-7, 18377823.
27. Hwang JH, Lee SH, Lee KH, Lee KY, Kim H, Ryu JK, Yoon YB, Kim YT. Cathepsin B is a target of hedgehog signaling in pancreatic cancer. Cancer Lett 2009, 273:266-272. 10.1016/j.canlet.2008.08.028, 19004543.